Unicorn Nest Logo

Avoro Ventures

avorocapital.com
Type

Venture Capital

Status

Active

Location

New York, United States

Total investments

12

Average round size

106M

Portfolio companies

11

Rounds per year

0.92

Follow on index

0.08

Exits

7

Areas of investment
BiotechnologyDrug DiscoveryHealth CareMedical DeviceMedicalLife SciencePharmaceuticalTherapeuticsBiopharmaAlternative Medicine

Investor highlights

Industry focus
Biotech/Life Sciences
Stage focus
Series BSeries CSeries D
Geo focus
Generalist

Discover reliable insights

Find relevant VC investors, identify key contacts and secure funding opportunities.

Find investors

Investments analytics

Analytics

Total investments
12
Lead investments
0
Exits
7
Rounds per year
0.92
Follow on index
0.08
Investments by industry
  • Biotechnology (12)
  • Health Care (7)
  • Biopharma (5)
  • Medical (5)
  • Therapeutics (5)
    • Show 6 more
Investments by region
  • United States (9)
  • Denmark (1)
  • Switzerland (1)
  • Ireland (1)
Peak activity year
2020

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.
Sign Up

Quantitative data

Avg. startup age at the time of investment
11
Avg. valuation at time of investment
8M
Group Appearance index
1.00
Avg. company exit year
4
Avg. multiplicator
0.13
Strategy success index
0.60

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Upgrade

Latest deals

Company name Deal date Industry Deal stage Deal size Location
Scribe Therapeutics 31 Mar 2021 Biotechnology, Life Science, Therapeutics Early Stage Venture 100M United States, California
How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.